These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B. Gao X, Jiao Y, Wang L, Liu X, Sun W, Cui B, Chen Z, Zhao Y. Clin Immunol; 2010 Oct; 137(1):139-46. PubMed ID: 20643584 [Abstract] [Full Text] [Related]
4. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis. Díaz-Peña R, Vidal-Castiñeira JR, Alonso-Arias R, Suarez-Alvarez B, Vicario JL, Solana R, Collantes E, López-Vázquez A, Martínez-Borra J, López-Larrea C. Arthritis Rheum; 2010 Apr; 62(4):1000-6. PubMed ID: 20131260 [Abstract] [Full Text] [Related]
8. Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis. Karlsen TH, Boberg KM, Olsson M, Sun JY, Senitzer D, Bergquist A, Schrumpf E, Thorsby E, Lie BA. J Hepatol; 2007 May; 46(5):899-906. PubMed ID: 17383044 [Abstract] [Full Text] [Related]
12. Distribution of the killer cell immunoglobulin-like receptors in Mexican Mestizos. Contreras G, Aláez C, Murguía A, García D, Flores H, Gorodezky C. Tissue Antigens; 2007 Apr; 69 Suppl 1():125-9. PubMed ID: 17445185 [Abstract] [Full Text] [Related]
13. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis. Littera R, Chessa L, Onali S, Figorilli F, Lai S, Secci L, La Nasa G, Caocci G, Arras M, Melis M, Cappellini S, Balestrieri C, Serra G, Conti M, Zolfino T, Casale M, Casu S, Pasetto MC, Barca L, Salustro C, Matta L, Scioscia R, Zamboni F, Faa G, Orrù S, Carcassi C. PLoS One; 2016 Apr; 11(1):e0146086. PubMed ID: 26744892 [Abstract] [Full Text] [Related]
18. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis]. Guo KY, Mei JZ, Yao KT. Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963 [Abstract] [Full Text] [Related]
19. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals. Naumova E, Mihaylova A, Stoitchkov K, Ivanova M, Quin L, Toneva M. Cancer Immunol Immunother; 2005 Feb; 54(2):172-8. PubMed ID: 15248031 [Abstract] [Full Text] [Related]